Read + Share
Goldfinger M, Mantzaris I, Shastri A, Saunthararajah Y, et al. A weekly low-dose regimen of decitabine and venetoclax is efficacious and less
myelotoxic in a racially diverse cohort. Blood 2024;144:2360-2363.
PMID: 39316768
|
 |
|
Goldfinger M, Mantzaris I, Shastri A, Saunthararajah Y, et al. A weekly low-dose regimen of decitabine and venetoclax is efficacious and less
myelotoxic in a racially diverse cohort. Blood 2024;144:2360-2363.
PMID: 39316768
|
|
|
|